Generated Narrative: Composition CompositionPmlcParacetamolDafalganEffCARAPMP004 Language: fr-CH Profile: PMLC Composition identifier: <a href="http://terminology.hl7.org/6.3.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:a0387092-2625-4fd3-a492-8b43cf616efa status: Final type: Medication management plan (record artifact) date: 2023-11-04 12:00:00+0200 author: Device: type = Pharmaceutical information system application software (physical object) title: Plan de médication confidentiality: normal custodian: Organization Association CARA
Medication management plan (record artifact)
Ce plan de médication a été généré automatiquement par le service eMedication CARA le 4 novembre 2023 à 10:00:00 UTC. Tous les traitements actifs sont considérés.
The original representation as a PDF file
Generated Narrative: Patient PatientCARAPMP004 Profile: CH EMED EPR Patient Michaël Christopher Karce Male, DoB: 1973-12-25 ( Medical record number (use: official, )) Active: true Marital Status: unbekannt Other Id: Medical record number/CARAPMP004 (use: secondary, )
Generated Narrative: Device DevicePmp Profile: CH EMED EPR Device DeviceNames - Name Type * PMP CARA v0.1 Model name type: Pharmaceutical information system application software (physical object) Versions - Value * 8153cba owner: Organization Association CARA
Pharmaceutical information system application software (physical object)
Generated Narrative: Organization OrganizationCara Profile: CH EMED EPR Organization identifier: GLN/7601001407428 name: Association CARA address: Route de la Corniche 3a Épalinges Vaud 1066 CH
Generated Narrative: MedicationStatement MedicationStatementParacetamolDafalganEffPmlc Language: fr-CH Profile: PMLC MedicationStatement CH EMED Extension Treatment Plan id: <a href="http://terminology.hl7.org/6.3.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:819febad-dc65-4548-a739-00d1b305c265 externalDocumentId: <a href="http://terminology.hl7.org/6.3.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:7062399b-61f2-4fb1-b6ba-415c7b6939bc CH EMED Extension Last Considered Document: <a href="http://terminology.hl7.org/6.3.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:31b60b8f-e15d-42ce-9558-57fde055da7a identifier: <a href="http://terminology.hl7.org/6.3.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:a98cc3c1-c079-471c-b053-93b01b70f8c4 status: Active medication: Medication DAFALGAN cpr eff 500mg subject: Michaël Christopher Karce Male, DoB: 1973-12-25 ( Medical record number (use: official, )) dateAsserted: 2023-11-04 12:00:00+0200 informationSource: PractitionerRole reasonCode: Difficulté à prendre comprimés pelliculés, substitution par comprimés effervescents. dosage text: 2 comprimés à avaler le matin et 2 comprimés le soir, du 2023-10-04 au 2024-02-10. timing: Morning, Evening, Once route: À avaler DoseAndRates - Dose[x] * 2 comprimé (Details: SNOMED CT code732936001 = 'Tablet (unit of presentation)') Generated Narrative: Medication #MedicationParacetamolDafalganEff Language: fr-CH Profile: CH EMED EPR Medication code: DAFALGAN cpr eff 500mg form: Comprimé effervescent amount: 40 comprimé (Details: SNOMED CT code732936001 = 'Tablet (unit of presentation)')/1 plaquette (Details: SNOMED CT code732984005 = 'Blister (unit of presentation)') Ingredients - Item[x] IsActive Strength * Paracétamol true 500 mg (Details: UCUM codemg = 'mg')/1 comprimé (Details: SNOMED CT code732936001 = 'Tablet (unit of presentation)') Generated Narrative: Organization #OrganizationHug Profile: CH EMED EPR Organization identifier: GLN/7601000234438 name: Hôpitaux universitaires de Genève address: Rue Gabrielle-Perret-Gentil 4 Genève 1205 CH Generated Narrative: Practitioner #PractitionerCox Profile: CH EMED EPR Practitioner identifier: GLN/7601000234438 name: Perry Cox Generated Narrative: PractitionerRole #PractitionerRoleCoxAtHug Profile: CH EMED EPR PractitionerRole practitioner: Practitioner Perry Cox organization: Organization Hôpitaux universitaires de Genève
Difficulté à prendre comprimés pelliculés, substitution par comprimés effervescents.
2 comprimés à avaler le matin et 2 comprimés le soir, du 2023-10-04 au 2024-02-10.